Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
about
Recruitment of hepatocyte nuclear factor 4 into specific intranuclear compartments depends on tyrosine phosphorylation that affects its DNA-binding and transactivation potentialRegulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genisteinIn vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosusNerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway.The Role of Natural Polyphenols in the Prevention and Treatment of Cervical Cancer-An OverviewEffects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedingsRole of tyrosine kinase activity in alpha-adrenergic inhibition of the beta-adrenergically regulated L-type Ca(2+) current in guinea-pig ventricular myocytesInvolvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cellsInterleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinaseRegulatory mechanisms involved in activator-protein-1 (AP-1)-mediated activation of glutathione-S-transferase gene expression by chemical agentsTyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase.TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase.Mechanisms of induction of human tissue inhibitor of metalloproteinases-1 (TIMP-1) gene expression by all-trans retinoic acid in combination with basic fibroblast growth factor.Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapyGenistein directly inhibits native and recombinant NMDA receptors.Electrophysiological evidence for the presence of cystic fibrosis transmembrane conductance regulator (CFTR) in mouse sperm.Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.Hyposmolality stimulates apical membrane Na(+)/H(+) exchange and HCO(3)(-) absorption in renal thick ascending limb.Clinical and pharmacological experience with LJP-394.Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis.Pharmacological treatment of the ion transport defect in cystic fibrosis.Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.Roles of p38 mitogen-activated protein kinase, NF-kappaB, and protein kinase C in proinflammatory cytokine mRNA expression by human peripheral blood leukocytes, monocytes, and neutrophils in response to Anaplasma phagocytophila.Acid activation of immediate early genes in renal epithelial cellsRecruitment of epidermal growth factor and transferrin receptors into coated pits in vitro: differing biochemical requirements.Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets.Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisPotent stimulation and inhibition of the CFTR Cl(-) current by phloxine B.Cardiac Na+-Ca2+ exchanger current induced by tyrphostin tyrosine kinase inhibitors.The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro.Insensitivity of cardiac delayed-rectifier I(Kr) to tyrosine phosphorylation inhibitors and stimulatorsTyrosine phosphorylation is required for ehrlichial internalization and replication in P388D1 cellsActivation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.Pharmacological approaches to correcting the ion transport defect in cystic fibrosis.A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.Activation of cardiac chloride conductance by the tyrosine kinase inhibitor, genistein.Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts.PDGF induction of alpha 2 integrin gene expression is mediated by protein kinase C-zeta.
P2860
Q24562874-88156C92-9044-4A31-8735-7403D1DAFF6DQ24642787-720952D9-4D47-4A16-AE4E-86079CB5FE19Q24674880-6AD7414A-F4F1-4032-BE21-281D8F6675D3Q24746252-8045F15D-7CCA-40F8-97C5-E235B5E19B54Q26739983-1097D11E-75B8-4AC7-8D1A-D3DB6249816EQ28208710-9B7FC260-5AF8-4920-AB18-E1E3A9DB77C1Q28264426-D66D5DEE-DE46-4542-86AD-BC650A86F90FQ28366503-82B96577-B363-42D4-9A9A-435507D7DFC1Q28589571-A50A4173-8A51-4EF9-88E3-21C6B31A979EQ28590956-4B57161A-A31D-4070-89A9-9E6305D4D26DQ28609827-BAA4CABC-5C07-46A6-9F5E-7ABCBCC40C57Q30177026-207C268C-7EF8-4446-A781-851D7A1EBA3CQ30739769-BC862B99-3F86-4346-AB86-592F0EEEA3C2Q31398792-9BEBC008-3BE3-4AD6-A366-C2BA98E1BFE6Q33333660-0766DFFC-AA94-4AFA-9370-08B3B7203195Q33817360-BDA685F0-E85A-457C-913C-3D351195CC83Q33825010-14535FA3-BB23-4924-AF52-A089FB8D8317Q33888599-0D3F152B-50A1-4D93-B84E-B6F2FA4F43F1Q33902339-017ACB85-1189-49BC-9266-9675064B5438Q33928115-2821330B-3ECC-499C-8812-09B83769815DQ34003470-E8C241CB-A903-4FD8-860E-591794D4B6A6Q34104575-B66FE05D-3C18-4099-BE89-102E5B9E20FBQ34123703-EBC67177-C3B6-48BF-B23E-5C78D7BC16AAQ34129079-79C6EE0C-B77B-4AC8-970D-B10FD9B8EDB4Q34186103-2E5C7B1E-F875-4BAE-8BE7-79A48C1E7635Q34438413-5E17F85C-CD3A-4A9C-A016-85EEA8D2123BQ34717968-EB3059CA-1551-495B-BE2B-F5CB8B887FE7Q34792827-667FE968-DD93-455A-AEE8-2E75D5FFDB16Q35025556-B6BEE1F0-740D-47E6-894A-713DBE54CB5EQ35042745-60E5F3EC-5F78-4302-BA45-1B7AF683976FQ35048466-13F3F418-F15F-473A-AF01-EC4F063D4086Q35048598-D8A06EB2-6372-4C0F-8541-66AC6DF67433Q35546183-5FE8D9F2-530C-4F0A-8949-FB59C4B6F618Q35551688-228FB016-F38D-4E4C-889F-73E2440E6DFEQ35553624-D4D32613-0000-403A-B27C-31920F547C5EQ35627639-01C28F58-AEC7-4375-876A-7221958566C1Q35884192-9AA86C60-AF2D-4C2A-8C11-CE45692256B1Q35884651-622571D4-F1C5-4F21-9B0C-983F23955DDDQ36097786-83C619E1-79CF-49E9-9AEA-D2AAE87F7DC2Q36237368-7AFE3D96-A6FF-4982-B606-454659A5304F
P2860
Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
@en
type
label
Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
@en
prefLabel
Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
@en
P1476
Use and specificity of genistein as inhibitor of protein-tyrosine kinases.
@en
P2093
P304
P356
10.1016/0076-6879(91)01032-W
P407
P577
1991-01-01T00:00:00Z